US 9248119
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
granted A61KA61K31/426A61K9/0004
Quick answer
US patent 9248119 (Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/426, A61K9/0004, A61K9/0053, A61K9/1629